Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.20 USD
Change Today 0.00 / 0.00%
Volume 0.0
RELV On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

reliv international inc (RELV) Snapshot

Open
$1.12
Previous Close
$1.20
Day High
$1.20
Day Low
$1.12
52 Week High
06/27/14 - $2.17
52 Week Low
04/10/15 - $1.06
Market Cap
15.4M
Average Volume 10 Days
19.6K
EPS TTM
$0.08
Shares Outstanding
12.8M
EX-Date
11/13/13
P/E TM
15.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for RELIV INTERNATIONAL INC (RELV)

Related News

No related news articles were found.

reliv international inc (RELV) Related Businessweek News

No Related Businessweek News Found

reliv international inc (RELV) Details

Reliv International Inc. develops, manufactures, and markets proprietary nutritional supplements addressing basic nutrition, specific wellness needs, weight management, and sports nutrition. It also offers skin-care products, including balanced cleansing gel, body renewal lotion, smooth-and-lift serum, daily skin defense, eye renewal cream, nightly skin restore, and rich cleansing bar. It markets its products through a network of independent distributors in the U.S., Australia, Austria, Canada, Germany, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and Britain. The company was founded in 1984 and is headquartered in Chesterfield, Mo.

195 Employees
Last Reported Date: 03/24/15
Founded in 1984

reliv international inc (RELV) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $631.9K
President of Asia-Pacific Region
Total Annual Compensation: $202.0K
Senior Vice President, General Counsel, Secre...
Total Annual Compensation: $236.0K
Vice Chairman, Chief Scientific Officer, Memb...
Total Annual Compensation: $354.0K
Compensation as of Fiscal Year 2014.

reliv international inc (RELV) Key Developments

Reliv International, Inc. Reports Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2015

Reliv International, Inc. reported unaudited consolidated financial results for the first quarter ended March 31, 2015. The company reported net sales of $14.8 million for the first quarter of 2015, compared to net sales of $14.5 million for the first quarter of 2014. The Company reported net income of $116,447, or $0.01 per diluted share, for the first quarter of 2015 compared to a net loss of $151,950, or $0.01 loss per diluted share, for the first quarter of 2014. Income from operations for the first quarter of 2015 was $429,000 compared to a loss of $170,000 in the same quarter of 2014. Income before income taxes was $116,447 compared to loss before income taxes of $150,950 a year ago.

Reliv International Unveils New Lunarich X Encapsulation Line

Reliv International, Inc. announced that the company has installed a new encapsulation line at Reliv headquarters to manufacture LunaRich X(TM), a concentrated lunasin supplement. Reliv made the announcement to its distributors this week via a one-minute video. LunaRich X is the most pure, concentrated form of bioactive lunasin ever produced. Since its launch in January 2013, LunaRich X was named Consumer Product of the Year by the American Business Awards, was shown to aid in promoting metabolic health in a University of Missouri study and has sold more than 12 million capsules worldwide.

Reliv International, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Reliv International, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales of $14.1 million compared with sales of $17.4 million for the fourth quarter of 2013. Net income was $998,000, or $0.08 per diluted share compared with net income of $503,000, or $0.04 per diluted share, for the fourth quarter of 2013. Income from operations was $513,000 compared with $888,000 in the same quarter of 2013. Income before income tax was $423,323 compared to $824,830 a year ago. For the full year, the company reported net sales of $57.3 million compared with net sales of $68.2 million in 2013. Net income was $725,000 compared with $777,000 in 2013. Earnings per diluted share were $0.06 for both 2014 and 2013. Net income was favorably impacted by the income tax benefit in the European subsidiary as previously noted. Income from operations was $96,000 compared to $1.5 million in 2013. Net cash of $392,000 was used in operating activities in 2014 compared to net cash of $2.5 million provided by operations in 2013. Loss before income tax was $23,431 compared to income before income tax of $4,431,590 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RELV:US $1.20 USD 0.00

RELV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lifevantage Corp $0.75 USD -0.02
Lifeway Foods Inc $20.09 USD -0.55
Mannatech Inc $19.44 USD -0.11
Natural Alternatives International Inc $5.58 USD -0.008
Natural Health Trends Corp $23.69 USD +0.87
View Industry Companies
 

Industry Analysis

RELV

Industry Average

Valuation RELV Industry Range
Price/Earnings 15.4x
Price/Sales 0.3x
Price/Book 0.9x
Price/Cash Flow 15.4x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RELIV INTERNATIONAL INC, please visit www.reliv.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.